跳至主要内容
临床试验/CTRI/2024/03/064365
CTRI/2024/03/064365招募中2 期

Efficacy of individualized homoeopathic medicines in improving symptoms of dry eye disease in adults: A double-blind, randomized, placebo-controlled trial - NI

D. N. De Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Individuals with an ocular surface disease index score (OSDI) 13 to 32(mild to moderate) and a Schirmer-1 test wetness of less than 15 millimeters.
  • 2. Individuals who are 18 to 65 years old.
  • 3. Patients of either gender or transgender.
  • 4. Participants having prior experience or knowledge of the treatment; e.g., primed to expect ‘homoeopathic aggravation’ and available treatment options for the disease conditions, intimated through Patient Information Sheet.

排除标准

  • 1. Individuals with OSDI score more than 32 (severe).
  • 2. Those who have had eye surgery or trauma during the last three months.
  • 3. Individuals who decline to provide written informed consent.
  • 4. Patients suffering from various ocular disorders, such as glaucoma or keratitis.
  • 5. A patient whose systemic disorders are the cause of their DED.
  • 6. Women who are breastfeeding or pregnant or in puerperium.
  • 7. Those suffering from any type of autoimmune condition, such as Sjogren syndrome, SLE, etc.
  • 8. Persons with simultaneous participation in any other clinical trial.
  • 9. Vulnerable population- Unconscious, non-ambulatory, too sick for consultation,
  • differently abled, terminally ill or critically ill patients, mentally incompetent people.
  • 10. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled
  • or life-threatening illness affecting quality of life or any organ failure.
  • 11. Tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence.
  • 12. Self-reported immune-compromised state AIDS, Hepatitis, etc.
  • 13. A person with uncontrolled diabetes or any other uncontrolled systemic disorders.
  • 14. A patient receiving continuous homoeopathic treatment for any other chronic illness.

研究者

发起方
D. N. De Homoeopathic Medical College and Hospital

相似试验